Article information
RESUMO
A propósito de um caso de Tromboembolismo Pulmonar (TEP), em mulher jovem a fazer anticonceptivo oral (ACO), os AA fazem uma revisão sumária dos ACO como factor de risco no TEP.
Palavras-chave:
Contracepção oral
Tromboembolismo pulmonar
Factores de risco vascular
SUMMARY
In reference to a clinical case of Pulmonary Thromboembolism (PTE) in a young woman taking oral contraceptives (OC), the authors review the role of OC as a risk factor in PTE.
Key-words:
Oral contraception
Pulmonary embolism
Vascular risk factors
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
Royal College of, General Practitioners.
Oral contraception and thromboembolic disease.
J Roy Gen Pract, 13 (1967), pp. 267-279
[2.]
M.P. Vessey.
Female hormones and vascular disease an epidemiological overview.
Br J Family Planing, 6 (1980), pp. 1-12
[3.]
H. Heijboer, D.P.M. Brandjes, H.R. Büller, et al.
Deficiencies of coagulation- inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
N. Engl J Med, 323 (1990), pp. 1512-1516
[4.]
C. Giuntini, G. Di Ricco, C. Marini, et al.
Epidemilogy of venous thromboembolism.
Chest, 107 (1995), pp. 3-9
[5.]
D.A. Quinn, B. Taylor Thompson, M.L. Terrin, et al.
A prospective investigation of pulmonary embolism in women and men.
JAMA, 268 (1992), pp. 1068-1072
[6.]
J.L. Beaumont, N. Lemort.
Oral contraceptives. pulmorary artery thrombosis and anti. ethinyl monoclonal IgG.
Clin Exp lmmunol, 24 (1976), pp. 455-463
[7.]
V. Beaumont, N. Lemort, J.L. Beaumont.
Oral contraception. circulating immune complexes. anti-ethinyloestradiol antibodies and thrombosis.
Am J Reprod lmmunol, 2 (1982), pp. 8-13
[8.]
V. Beaumont, N. Lemort, J.L. Beaumont.
Complications vasculaires de la contraception orale. Chez qui et comment les prévenir.
Presse Méd, 12 (1983), pp. 2977-2981
[9.]
R. Bucala, G. Lahita, J. Fishman, et al.
Antiestrogen antibodies in users of oral contraceptives and in patients with systemic lupus erythematous.
Clin Exp Immunol, 67 (1987), pp. 167-175
[10.]
J.H. Engel, E. Engel, P.R. Lichten.
Coronary atherosclerosis and myocardial infarction in young women. Role of oral contraceptives.
Eur Heart J, 2 (1983), pp. 1-8
[11.]
N.S. Irey, W.C. Manion, H.B. Taylor.
Vascular lesions in women taking oral contraceptives.
Arch Path, 89 (1970), pp. 1-8
[12.]
B.B. Gerstman, I.M. Piper, D.K. Tomita, et al.
Oral contraceptive estrogen dose and risk of deep venous thromboembolic disease.
Am J Epidemiol, 133 (1991), pp. 32-37
[13.]
B.B. Gerstman, I.M. Piper, I.P. Freiman, et al.
Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism.
lnt J Epidemiol, 19 (1990), pp. 1-6
Copyright © 1996. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Recommended
articles
articles
10.1016/j.pulmoe.2023.12.004
10.1016/j.pulmoe.2023.10.002
Pulmonol. 2022;28:368-75
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options